Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025
The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even hotter due to AI.
Accolade Inc. (ACCD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 132,598,000 | $124,471,069 | 2.35% | ||
| 2. | ARK Investment Management Catherine D. Wood | 4,663,613 | $15,949,557 | -14% | 0.13% |
| 3. | Deerfield Management James E. Flynn | 3,475,000 | $11,884,500 | 0.22% | |
| 4. | Millennium Management Israel Englander | 3,090,861 | $10,570,745 | -23% | 0% |
| 5. | 8,730,000 | $8,249,850 | 0.36% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.04 | 74 | Officer | 121,564 | 2022-08-02 | Filing | |
| $10.09 | 17,500 | Officer, Director | 149,697 | 2022-08-02 | Filing | |
| $10.09 | 17,500 | Officer, Director | 149,697 | 2022-08-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.90 | 180 | Officer | 216,889 | 2025-02-19 | Filing | |
| $6.90 | 137 | Officer | 302,190 | 2025-02-19 | Filing | |
| $6.90 | 279 | Officer, Director | 824,622 | 2025-02-19 | Filing | |
| $6.89 | 509 | Officer, Director | 823,968 | 2025-02-11 | Filing | |
| $6.89 | 252 | Officer | 216,559 | 2025-02-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 32,083,000 | $30,191,502 | 0.25% | |
| 2. | 25,991 | $24,431,514 | 0.95% | |
| 3. | 6,227,049 | $21,296,509 | 0% | |
| 4. | 5,398,708 | $18,463,581 | 2.47% | |
| 5. | 4,181,387 | $14,300,343 | 0% |
News See All
10 Hottest Smid-Cap Stocks So Far In 2025
As the name suggests, smid-cap stocks have a valuation between $200 million and $20 billion. The definition is pretty flexible, but I'll be working with the broadest one.
Accolade, Inc. (NASDAQ:ACCD) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Accolade Second Quarter 2025 Earnings Results Conference Call. At this time, all participants are in a listen-only mode.
Accolade, Inc. (NASDAQ:ACCD) Q1 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Accolade First Quarter 2025 Earnings Results Conference Call. At this time, all participants are in a listen-only mode.
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
Can Accolade (ACCD) Sustain an Annual Revenue Growth Rate of 20%?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript
Accolade, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.11. Accolade, Inc.
10 Cathie Wood Stocks Insiders are Selling
There was a time Cathie Wood talked about her famous "five-year investment horizon" with confidence, giving investors hope that the high-growth, cash-burning companies she was betting on would pay off...
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.
Accolade, Inc. (NASDAQ:ACCD) Q3 2024 Earnings Call Transcript
Accolade, Inc. beats earnings expectations. Reported EPS is $-0.28, expectations were $-0.46.
Billionaire Hedge Funds
